Speaker

David de Graaf

Co-Founder, CEO & President, Reverb Therapeutics Inc.

David de Graaf, Co-Founder, CEO & President at Reverb Therapeutics Inc., spoke at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Leveraging Novel T-Cell Engagement Mechanisms to Expand the Therapeutic Window Through Improved Precision, Safety & Immune Modulation”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- SpeakerLeveraging Novel T-Cell Engagement Mechanisms to Expand the Therapeutic Window Through Improved Precision, Safety & Immune Modulation

More speakers at 2nd T-Cell Engager for Autoimmune Disease Summit

Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Giovanni Abbadessa
Chief Medical Officer, ModeX Therapeutics
Patrick Baeuerle
Chief Scientific Advisor & Chairman of Scientific Advisory Board, Cullinan Therapeutics, Inc.
Xingfeng Bao
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Alexander Boches
Chief Business Officer, NovalGen
Elaine Chen
Senior Scientist, Translational Biology, Rondo Therapeutics

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by David de Graaf, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].